Endometriosis and Uterine Fibroids (Leiomyomata): Comorbidity, Risks and Implications
- PMID: 36304022
- PMCID: PMC9580755
- DOI: 10.3389/frph.2021.750018
Endometriosis and Uterine Fibroids (Leiomyomata): Comorbidity, Risks and Implications
Abstract
Uterine Fibroids (leiomyomata) and endometriosis affect millions of women world-wide. Although aetiology and natural history of the conditions are markedly different, symptoms can overlap and make differential diagnoses necessary, often using invasive methods such as laparoscopy. Considerable comorbidity exists between the two conditions and needs to be taken into account when treating fibroids and/or endometriosis. The genetic foundations of both uterine fibroids and endometriosis remain to be fully understood but recent evidence suggest common underpinnings. Here, we discuss the comorbidity of uterine fibroids and endometriosis and the implications for diagnosis, treatment and risks.
Keywords: comorbidity; endometriosis; leiomyoma; symptoms; uterine fibroids.
Copyright © 2021 Uimari, Nazri and Tapmeier.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Assessment of a Digital Symptom Checker Tool's Accuracy in Suggesting Reproductive Health Conditions: Clinical Vignettes Study.JMIR Mhealth Uhealth. 2023 Dec 5;11:e46718. doi: 10.2196/46718. JMIR Mhealth Uhealth. 2023. PMID: 38051574 Free PMC article.
-
Do symptomatic endometriosis and uterine fibroids appear together?J Hum Reprod Sci. 2011 Jan;4(1):34-8. doi: 10.4103/0974-1208.82358. J Hum Reprod Sci. 2011. PMID: 21772738 Free PMC article.
-
Protocol for a longitudinal, prospective cohort study investigating the biology of uterine fibroids and endometriosis, and patients' quality of life: the FENOX study.BMJ Open. 2020 Mar 4;10(3):e032220. doi: 10.1136/bmjopen-2019-032220. BMJ Open. 2020. PMID: 32139480 Free PMC article.
-
Drug delivery for the treatment of endometriosis and uterine fibroids.Drug Deliv Transl Res. 2017 Dec;7(6):829-839. doi: 10.1007/s13346-017-0423-2. Drug Deliv Transl Res. 2017. PMID: 28828592 Review.
-
MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?Hum Reprod Update. 2014 Sep-Oct;20(5):670-87. doi: 10.1093/humupd/dmu017. Epub 2014 Apr 4. Hum Reprod Update. 2014. PMID: 24706045 Review.
Cited by
-
Improving Replication in Endometrial Omics: Understanding the Influence of the Menstrual Cycle.Int J Mol Sci. 2025 Jan 20;26(2):857. doi: 10.3390/ijms26020857. Int J Mol Sci. 2025. PMID: 39859570 Free PMC article. Review.
-
Uterine Fibroids (Leiomyomata) and Heavy Menstrual Bleeding.Front Reprod Health. 2022 Mar 4;4:818243. doi: 10.3389/frph.2022.818243. eCollection 2022. Front Reprod Health. 2022. PMID: 36303616 Free PMC article. Review.
-
Whole-exome sequencing reveals candidate high-risk susceptibility genes for endometriosis.Hum Genomics. 2023 Oct 3;17(1):88. doi: 10.1186/s40246-023-00538-9. Hum Genomics. 2023. PMID: 37789421 Free PMC article.
-
The role of small extracellular vesicle-miRNAs in endometriosis.Hum Reprod. 2023 Dec 4;38(12):2296-2311. doi: 10.1093/humrep/dead216. Hum Reprod. 2023. PMID: 37877421 Free PMC article. Review.
-
Reversing Uteropathies Including Cancer-Like Changes in Mice by Transplanting Mesenchymal Stromal Cells or XAR Treatment.Stem Cell Rev Rep. 2024 Jan;20(1):258-282. doi: 10.1007/s12015-023-10632-z. Epub 2023 Oct 2. Stem Cell Rev Rep. 2024. PMID: 37779174
References
Publication types
LinkOut - more resources
Full Text Sources